Concepedia

Michelle B. Miranda

MB

6

Publications

311

Citations

6

H-Index

2005

Active since

Affiliations

UPMC Hillman Cancer Center(Current)

University of Pittsburgh

Immunovaccine (Canada)

Michelle B. Miranda is an author at UPMC Hillman Cancer Center specializing in medicine, immunology, and cell signaling.

Top concepts

Publications per year

2005–2022

6

Publications

6

Involvement of cathepsin D in chemotherapy-induced cytochrome <i>c</i> release, caspase activation, and cell death

Lori A. Emert‐Sedlak, Sanjeev Shangary, Asaf Rabinovitz et al. · Molecular Cancer Therapeutics · 2005 · 90 citations

Cytokine-induced myeloid differentiation is dependent on activation of the MEK/ERK pathway

Michelle B. Miranda, Hong Xu, James A. Torchia et al. · Leukemia Research · 2005 · 60 citations

, , +11

(−)-Gossypol acts directly on the mitochondria to overcome Bcl-2- and Bcl-XL-mediated apoptosis resistance

Christopher L. Oliver, Michelle B. Miranda, Sanjeev Shangary et al. · Molecular Cancer Therapeutics · 2005 · 59 citations · Full text

, , +20

Targeting Antiapoptotic Bcl-2 Family Members with Cell-Permeable BH3 Peptides Induces Apoptosis Signaling, Death in Head, Neck Squamous Cell Carcinoma Cells

Rongxiu Li, Amanda L. Boehm, Michelle B. Miranda et al. · Neoplasia · 2007 · 53 citations · Full text

Inhibition of Src family kinases enhances retinoic acid–induced gene expression and myeloid differentiation

Michelle B. Miranda, Robert L. Redner, Daniel E. Johnson · Molecular Cancer Therapeutics · 2007 · 31 citations

Rows per page

1–5 of 6